UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $249,000 | -29.9% | 43,010 | -12.7% | 0.10% | +75.9% |
Q4 2019 | $355,000 | +100.6% | 49,283 | +70.3% | 0.06% | +61.1% |
Q3 2019 | $177,000 | -39.0% | 28,942 | -5.3% | 0.04% | -41.0% |
Q2 2019 | $290,000 | +116.4% | 30,554 | +84.8% | 0.06% | -78.6% |
Q1 2019 | $134,000 | -56.6% | 16,533 | -12.9% | 0.28% | +437.7% |
Q4 2018 | $309,000 | – | 18,987 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
PDT Partners, LLC | 74,178 | $344,000 | 0.02% |